Copyright Reports & Markets. All rights reserved.

Global Botanical Plant Derived Drug Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Botanical Plant Derived Drug by Type
    • 1.3.1 Overview: Global Botanical Plant Derived Drug Market Size by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Global Botanical Plant Derived Drug Consumption Value Market Share by Type in 2024
    • 1.3.3 Pill
    • 1.3.4 Tablet
    • 1.3.5 Capsule
  • 1.4 Global Botanical Plant Derived Drug Market by Application
    • 1.4.1 Overview: Global Botanical Plant Derived Drug Market Size by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Pharmacy
    • 1.4.3 Clinic Center
    • 1.4.4 Others
  • 1.5 Global Botanical Plant Derived Drug Market Size & Forecast
  • 1.6 Global Botanical Plant Derived Drug Market Size and Forecast by Region
    • 1.6.1 Global Botanical Plant Derived Drug Market Size by Region: 2020 VS 2024 VS 2031
    • 1.6.2 Global Botanical Plant Derived Drug Market Size by Region, (2020-2031)
    • 1.6.3 North America Botanical Plant Derived Drug Market Size and Prospect (2020-2031)
    • 1.6.4 Europe Botanical Plant Derived Drug Market Size and Prospect (2020-2031)
    • 1.6.5 Asia-Pacific Botanical Plant Derived Drug Market Size and Prospect (2020-2031)
    • 1.6.6 South America Botanical Plant Derived Drug Market Size and Prospect (2020-2031)
    • 1.6.7 Middle East & Africa Botanical Plant Derived Drug Market Size and Prospect (2020-2031)

2 Company Profiles

  • 2.1 Abbott Laboratories
    • 2.1.1 Abbott Laboratories Details
    • 2.1.2 Abbott Laboratories Major Business
    • 2.1.3 Abbott Laboratories Botanical Plant Derived Drug Product and Solutions
    • 2.1.4 Abbott Laboratories Botanical Plant Derived Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Abbott Laboratories Recent Developments and Future Plans
  • 2.2 Eli Lilly
    • 2.2.1 Eli Lilly Details
    • 2.2.2 Eli Lilly Major Business
    • 2.2.3 Eli Lilly Botanical Plant Derived Drug Product and Solutions
    • 2.2.4 Eli Lilly Botanical Plant Derived Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Eli Lilly Recent Developments and Future Plans
  • 2.3 Medigene
    • 2.3.1 Medigene Details
    • 2.3.2 Medigene Major Business
    • 2.3.3 Medigene Botanical Plant Derived Drug Product and Solutions
    • 2.3.4 Medigene Botanical Plant Derived Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Medigene Recent Developments and Future Plans
  • 2.4 Pfizer
    • 2.4.1 Pfizer Details
    • 2.4.2 Pfizer Major Business
    • 2.4.3 Pfizer Botanical Plant Derived Drug Product and Solutions
    • 2.4.4 Pfizer Botanical Plant Derived Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Pfizer Recent Developments and Future Plans
  • 2.5 Lupin
    • 2.5.1 Lupin Details
    • 2.5.2 Lupin Major Business
    • 2.5.3 Lupin Botanical Plant Derived Drug Product and Solutions
    • 2.5.4 Lupin Botanical Plant Derived Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Lupin Recent Developments and Future Plans
  • 2.6 Johnson & Johnson
    • 2.6.1 Johnson & Johnson Details
    • 2.6.2 Johnson & Johnson Major Business
    • 2.6.3 Johnson & Johnson Botanical Plant Derived Drug Product and Solutions
    • 2.6.4 Johnson & Johnson Botanical Plant Derived Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Johnson & Johnson Recent Developments and Future Plans
  • 2.7 Ranbaxy Laboratories
    • 2.7.1 Ranbaxy Laboratories Details
    • 2.7.2 Ranbaxy Laboratories Major Business
    • 2.7.3 Ranbaxy Laboratories Botanical Plant Derived Drug Product and Solutions
    • 2.7.4 Ranbaxy Laboratories Botanical Plant Derived Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Ranbaxy Laboratories Recent Developments and Future Plans
  • 2.8 Novartis International AG
    • 2.8.1 Novartis International AG Details
    • 2.8.2 Novartis International AG Major Business
    • 2.8.3 Novartis International AG Botanical Plant Derived Drug Product and Solutions
    • 2.8.4 Novartis International AG Botanical Plant Derived Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Novartis International AG Recent Developments and Future Plans
  • 2.9 Glaxosmithkline
    • 2.9.1 Glaxosmithkline Details
    • 2.9.2 Glaxosmithkline Major Business
    • 2.9.3 Glaxosmithkline Botanical Plant Derived Drug Product and Solutions
    • 2.9.4 Glaxosmithkline Botanical Plant Derived Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Glaxosmithkline Recent Developments and Future Plans
  • 2.10 Leo Pharma
    • 2.10.1 Leo Pharma Details
    • 2.10.2 Leo Pharma Major Business
    • 2.10.3 Leo Pharma Botanical Plant Derived Drug Product and Solutions
    • 2.10.4 Leo Pharma Botanical Plant Derived Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Leo Pharma Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Botanical Plant Derived Drug Revenue and Share by Players (2020-2025)
  • 3.2 Market Share Analysis (2024)
    • 3.2.1 Market Share of Botanical Plant Derived Drug by Company Revenue
    • 3.2.2 Top 3 Botanical Plant Derived Drug Players Market Share in 2024
    • 3.2.3 Top 6 Botanical Plant Derived Drug Players Market Share in 2024
  • 3.3 Botanical Plant Derived Drug Market: Overall Company Footprint Analysis
    • 3.3.1 Botanical Plant Derived Drug Market: Region Footprint
    • 3.3.2 Botanical Plant Derived Drug Market: Company Product Type Footprint
    • 3.3.3 Botanical Plant Derived Drug Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Botanical Plant Derived Drug Consumption Value and Market Share by Type (2020-2025)
  • 4.2 Global Botanical Plant Derived Drug Market Forecast by Type (2026-2031)

5 Market Size Segment by Application

  • 5.1 Global Botanical Plant Derived Drug Consumption Value Market Share by Application (2020-2025)
  • 5.2 Global Botanical Plant Derived Drug Market Forecast by Application (2026-2031)

6 North America

  • 6.1 North America Botanical Plant Derived Drug Consumption Value by Type (2020-2031)
  • 6.2 North America Botanical Plant Derived Drug Market Size by Application (2020-2031)
  • 6.3 North America Botanical Plant Derived Drug Market Size by Country
    • 6.3.1 North America Botanical Plant Derived Drug Consumption Value by Country (2020-2031)
    • 6.3.2 United States Botanical Plant Derived Drug Market Size and Forecast (2020-2031)
    • 6.3.3 Canada Botanical Plant Derived Drug Market Size and Forecast (2020-2031)
    • 6.3.4 Mexico Botanical Plant Derived Drug Market Size and Forecast (2020-2031)

7 Europe

  • 7.1 Europe Botanical Plant Derived Drug Consumption Value by Type (2020-2031)
  • 7.2 Europe Botanical Plant Derived Drug Consumption Value by Application (2020-2031)
  • 7.3 Europe Botanical Plant Derived Drug Market Size by Country
    • 7.3.1 Europe Botanical Plant Derived Drug Consumption Value by Country (2020-2031)
    • 7.3.2 Germany Botanical Plant Derived Drug Market Size and Forecast (2020-2031)
    • 7.3.3 France Botanical Plant Derived Drug Market Size and Forecast (2020-2031)
    • 7.3.4 United Kingdom Botanical Plant Derived Drug Market Size and Forecast (2020-2031)
    • 7.3.5 Russia Botanical Plant Derived Drug Market Size and Forecast (2020-2031)
    • 7.3.6 Italy Botanical Plant Derived Drug Market Size and Forecast (2020-2031)

8 Asia-Pacific

  • 8.1 Asia-Pacific Botanical Plant Derived Drug Consumption Value by Type (2020-2031)
  • 8.2 Asia-Pacific Botanical Plant Derived Drug Consumption Value by Application (2020-2031)
  • 8.3 Asia-Pacific Botanical Plant Derived Drug Market Size by Region
    • 8.3.1 Asia-Pacific Botanical Plant Derived Drug Consumption Value by Region (2020-2031)
    • 8.3.2 China Botanical Plant Derived Drug Market Size and Forecast (2020-2031)
    • 8.3.3 Japan Botanical Plant Derived Drug Market Size and Forecast (2020-2031)
    • 8.3.4 South Korea Botanical Plant Derived Drug Market Size and Forecast (2020-2031)
    • 8.3.5 India Botanical Plant Derived Drug Market Size and Forecast (2020-2031)
    • 8.3.6 Southeast Asia Botanical Plant Derived Drug Market Size and Forecast (2020-2031)
    • 8.3.7 Australia Botanical Plant Derived Drug Market Size and Forecast (2020-2031)

9 South America

  • 9.1 South America Botanical Plant Derived Drug Consumption Value by Type (2020-2031)
  • 9.2 South America Botanical Plant Derived Drug Consumption Value by Application (2020-2031)
  • 9.3 South America Botanical Plant Derived Drug Market Size by Country
    • 9.3.1 South America Botanical Plant Derived Drug Consumption Value by Country (2020-2031)
    • 9.3.2 Brazil Botanical Plant Derived Drug Market Size and Forecast (2020-2031)
    • 9.3.3 Argentina Botanical Plant Derived Drug Market Size and Forecast (2020-2031)

10 Middle East & Africa

  • 10.1 Middle East & Africa Botanical Plant Derived Drug Consumption Value by Type (2020-2031)
  • 10.2 Middle East & Africa Botanical Plant Derived Drug Consumption Value by Application (2020-2031)
  • 10.3 Middle East & Africa Botanical Plant Derived Drug Market Size by Country
    • 10.3.1 Middle East & Africa Botanical Plant Derived Drug Consumption Value by Country (2020-2031)
    • 10.3.2 Turkey Botanical Plant Derived Drug Market Size and Forecast (2020-2031)
    • 10.3.3 Saudi Arabia Botanical Plant Derived Drug Market Size and Forecast (2020-2031)
    • 10.3.4 UAE Botanical Plant Derived Drug Market Size and Forecast (2020-2031)

11 Market Dynamics

  • 11.1 Botanical Plant Derived Drug Market Drivers
  • 11.2 Botanical Plant Derived Drug Market Restraints
  • 11.3 Botanical Plant Derived Drug Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Botanical Plant Derived Drug Industry Chain
  • 12.2 Botanical Plant Derived Drug Upstream Analysis
  • 12.3 Botanical Plant Derived Drug Midstream Analysis
  • 12.4 Botanical Plant Derived Drug Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Botanical Plant Derived Drug market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    This report is a detailed and comprehensive analysis for global Botanical Plant Derived Drug market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Botanical Plant Derived Drug market size and forecasts, in consumption value ($ Million), 2020-2031
    Global Botanical Plant Derived Drug market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
    Global Botanical Plant Derived Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
    Global Botanical Plant Derived Drug market shares of main players, in revenue ($ Million), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Botanical Plant Derived Drug
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Botanical Plant Derived Drug market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott Laboratories, Eli Lilly, Medigene, Pfizer, Lupin, Johnson & Johnson, Ranbaxy Laboratories, Novartis International AG, Glaxosmithkline, Leo Pharma, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Botanical Plant Derived Drug market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Pill
    Tablet
    Capsule
    Market segment by Application
    Pharmacy
    Clinic Center
    Others
    Market segment by players, this report covers
    Abbott Laboratories
    Eli Lilly
    Medigene
    Pfizer
    Lupin
    Johnson & Johnson
    Ranbaxy Laboratories
    Novartis International AG
    Glaxosmithkline
    Leo Pharma
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Botanical Plant Derived Drug product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Botanical Plant Derived Drug, with revenue, gross margin, and global market share of Botanical Plant Derived Drug from 2020 to 2025.
    Chapter 3, the Botanical Plant Derived Drug competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Botanical Plant Derived Drug market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Botanical Plant Derived Drug.
    Chapter 13, to describe Botanical Plant Derived Drug research findings and conclusion.

    Buy now